Kansure 30mg/5ml (Paclitaxel Vials) 30mg/5ml

Kansure 30mg/5ml is an injectable chemotherapy medication used in cancer treatment. This vial form contains paclitaxel, a taxane derivative, for intravenous administration. Store between 15-25°C and protect from light. Always handle with care.

Strength

30mg/5ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Khandelwal Laboratories Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Paclitaxel is primarily used to treat various cancers including ovarian, breast, lung, and Kaposi's sarcoma. It works by stabilizing microtubules to prevent cell division. This medication is often prescribed when other treatments have not been effective. Kansure 30mg/5ml provides the active ingredient in a ready-to-use vial form.

Side Effects

Paclitaxel may cause temporary effects such as hair thinning, nausea, or fatigue during treatment. Some patients report joint or muscle pain shortly after administration. These effects vary by individual and typically resolve between treatment cycles. The medication targets rapidly dividing cells, which includes both cancerous and some healthy cells.

Precautions & Warnings

Handle this medication with care as it may cause irritation if it comes into contact with skin or mucous membranes. Use protective gloves and avoid inhalation of vapors. Keep vials in their original packaging until ready for use. Discard any unused portion according to local medical waste guidelines.

Avoid Interactions

Paclitaxel may interact with other medications that affect liver enzymes, potentially altering its effectiveness. Drugs like ketoconazole or rifampin can impact how the body processes paclitaxel. Always inform your healthcare provider about all medications being taken. Alcohol use should be discussed with a medical professional during treatment.

References

Frequently Asked Questions

Kansure 30mg/5ml contains paclitaxel, used to treat certain cancers like ovarian, breast, and lung cancer.

Store between 15-25°C and protect from light. Keep vials in their original packaging until use.

No, use protective gloves and avoid skin contact or inhalation of vapors.

Yes, it may interact with drugs that affect liver enzymes. Always disclose all medications to your healthcare provider.

Yes, paclitaxel is a chemotherapy medication used to treat cancer.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.